While all state Medicaid programs cover GLP-1 agonists for type 2 diabetes, it’s much less common for them to cover the drugs ...

The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET ...

This is the second time a new Alzheimer's treatment has been rejected by the health spending watchdog in a matter of months.

From dreams deferred to daily struggles, North Carolinians share their harrowing battles with medical debt and the hope a new ...

India's rural healthcare system faces critical challenges, including a severe shortage of skilled professionals. Namrata ...

Despite the benefits of such medicines, like Wegovy, Saxenda and Zepbound, many people who could most benefit from them can’t ...

Panav Biotech proudly introduces Maropitine injection, an effective treatment for nausea and vomiting in pets.

In a CT Mirror poll, nearly half of voters identified abortion and reproductive rights as an issue important to them this ...

The British public did not fail to disappoint after the government launched a public consultation to shape up the NHS.

The coroner's findings into the cause of Clare Bremner, Maurice O’Donnell, Mona Tuwhangai and Bremner’s deaths on October 4, ...

Donanemab (also called Kisunla and made by Eli Lilly) has been licensed today by the MHRA for treatment of mild cognitive impairment or mild dementia due to Alzheimer’s disease in some adults. It is a ...